Bench to Bedside With SIDP C difficile COVID Vaccine Race PrEP

Bench to Bedside With SIDP C difficile COVID Vaccine Race PrEP

View More Coronavirus Antimicrobial Stewardship Blood-Borne Diseases Food-Borne Infections Gastrointestinal Infections Healthcare-Associated Infections Prevention Respiratory Diseases Sexually Transmitted Diseases Skin & Soft Tissue Diseases Zoonotic & Vector-Borne Diseases

Coronavirus Antimicrobial Stewardship Blood-Borne Diseases Food-Borne Infections Gastrointestinal Infections Healthcare-Associated Infections Prevention Respiratory Diseases Sexually Transmitted Diseases Skin & Soft Tissue Diseases Zoonotic & Vector-Borne Diseases

Insights Peer Exchange Peers and Perspectives

Insights Peer Exchange Peers and Perspectives

Medical World News

Medical World News Podcasts Videos Insights Peer Exchange

Conference Coverage

Conference Listing

Conference Coverage Conference Listing

Publications CME/CE

Interactive Tools

Special Projects

Interactive Tools Partners Special Projects

Print Subscription

eNewsletter Print Subscription

About Us
Advertise
Editorial
Contact Us
Do Not Sell My Information
Privacy
Terms & Conditions

© 2021 MJH Life Sciences and Contagion Live. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

Bench to Bedside With SIDP
C difficile
COVID Vaccine Race
PrEP

ClinicalSee All >

Coronavirus
Antimicrobial Stewardship
Blood-Borne Diseases
Food-Borne Infections
Gastrointestinal Infections
Healthcare-Associated Infections
Prevention
Respiratory Diseases
Sexually Transmitted Diseases
Skin & Soft Tissue Diseases
Zoonotic & Vector-Borne Diseases

Video Series

Insights
Peer Exchange
Peers and Perspectives

hcplive podcasts

About Us
Advertise
Editorial
Contact Us
Do Not Sell My Information
Privacy
Terms & Conditions

© 2021 MJH Life Sciences^™ and Contagion Live. All rights reserved.

Advances in the Treatment Landscape for HIV

EP. 1: Burden of HIV in the USA and Associated Symptoms

March 27th 2020

EP. 2: Screening Recommendations for HIV and Risk Stratification

March 27th 2020

EP. 3: PrEP Therapy for High-Risk HIV Candidates

March 27th 2020

EP. 4: Safety Profiles of FDA-Approved PrEP Agents

March 27th 2020

EP. 5: State Medicaid Reimbursement for Routine HIV Screening

March 27th 2020

EP. 6: Rapid Initiation of HIV Treatment With ART

March 27th 2020

EP. 7: Factors Considered in Choosing Initial HIV Therapeutic Regimen

March 27th 2020

EP. 8: Safety Profile and Costs of Initial HIV Therapeutic Regimen

March 27th 2020

EP. 9: Switching Therapies in Patients Who Are Successfully Treated

March 27th 2020

EP. 10: Virological Failure or Rebound to HIV Therapies

March 27th 2020